ISIN | CH0461413939 |
---|---|
Valor Number | 46141393 |
Bloomberg Global ID | |
Fund Name | Swisscanto (CH) Index Equity Fund United Kingdom NT GBP |
Fund Provider |
Swisscanto Fondsleitung AG
Zurich E-Mail: fonds@swisscanto.ch |
Fund Provider | Swisscanto Fondsleitung AG |
Representative in Switzerland | |
Distributor(s) | Schweizerische Kantonalbanken |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Switzerland |
Issuing Condition | The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets) |
Redemption Condition | The fund charges a transaction fee (contribution towards covering expenses incurred in the sale of assets) |
Investment Strategy *** | Die Anlagen dieses Teilvermögens erfolgen in Anlehnung an den MSCI® United Kingdom Index, welcher von der MORGAN STANLEY CAPITAL INTERNATIONAL INC. (MSCI) fest-gelegt und berechnet wird und darauf ausgelegt ist, die Performance der Mid- und Large Cap Segmente des Marktes des Vereinigten Königreiches (Grossbritannien und Nordirland) zu messen. |
Peculiarities |
Current Price * | 135.29 GBP | 17.04.2025 |
---|---|---|
Previous Price * | 135.16 GBP | 16.04.2025 |
52 Week High * | 143.64 GBP | 03.03.2025 |
52 Week Low * | 124.25 GBP | 18.04.2024 |
NAV * | 135.29 GBP | 17.04.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 133,256,266 | |
Unit/Share Assets *** | 117,141,742 | |
Trading Information SIX |
YTD Performance | +2.76% |
31.12.2024 - 17.04.2025
31.12.2024 17.04.2025 |
---|---|---|
YTD Performance (in CHF) | -1.63% |
31.12.2024 - 17.04.2025
31.12.2024 17.04.2025 |
1 month | -4.30% |
17.03.2025 - 17.04.2025
17.03.2025 17.04.2025 |
3 months | -1.24% |
17.01.2025 - 17.04.2025
17.01.2025 17.04.2025 |
6 months | +0.60% |
17.10.2024 - 17.04.2025
17.10.2024 17.04.2025 |
1 year | +9.27% |
17.04.2024 - 17.04.2025
17.04.2024 17.04.2025 |
2 years | +13.22% |
17.04.2023 - 17.04.2025
17.04.2023 17.04.2025 |
3 years | +21.99% |
19.04.2022 - 17.04.2025
19.04.2022 17.04.2025 |
5 years | +74.51% |
17.04.2020 - 17.04.2025
17.04.2020 17.04.2025 |
Equity Participation Rate in % | 97.37 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
AstraZeneca PLC | 8.68% | |
---|---|---|
Shell PLC | 8.56% | |
HSBC Holdings PLC | 7.77% | |
Unilever PLC | 5.68% | |
RELX PLC | 3.59% | |
BP PLC | 3.51% | |
Rolls-Royce Holdings PLC | 3.18% | |
British American Tobacco PLC | 3.16% | |
GSK PLC | 3.03% | |
London Stock Exchange Group PLC | 2.74% | |
Last data update | 31.03.2025 |
TER | 0.00% |
---|---|
TER date | 30.09.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | |
Ongoing Charges *** | 0.00% |
SRRI ***
|
|
SRRI date *** | 31.03.2025 |